Abstract:Immuno-oncology holds promise for transforming patient care having achieved durable clinical response rates across a variety of advanced and metastatic cancers. Despite these achievements, only a minority of patients respond to immunotherapy, underscoring the importance of elucidating molecular mechanisms responsible for response and resistance to inform the development and selection of treatments. Breakthroughs in molecular sequencing technologies have led to the generation of an immense amount of genomic and transcriptomic sequencing data that can be mined to uncover complex tumor-immune interactions using computational tools. In this review, we discuss existing and emerging computational methods that contextualize the composition and functional state of the tumor microenvironment, infer the reactivity and clonal dynamics from reconstructed immune cell receptor repertoires, and predict the antigenic landscape for immune cell recognition. We further describe the advantage of multi-omics analyses for capturing multidimensional relationships and artificial intelligence techniques for integrating omics data with histopathological and radiological images to encapsulate patterns of treatment response and tumor-immune biology. Finally, we discuss key challenges impeding their widespread use and clinical application and conclude with future perspectives. We are hopeful that this review will both serve as a guide for prospective researchers seeking to use existing tools for scientific discoveries and inspire the optimization or development of novel tools to enhance precision, ultimately expediting advancements in immunotherapy that improve patient survival and quality of life.

Computational Methods in Immunology and Vaccinology: Design and Development of Antibodies and Immunogens

A Novel Immune Algorithm for Complex Optimization Problems

Editorial: Decoding Immunologic Complex Systems in Cancer: the Cutting-Edge Technologies Revolutionizing Cancer Immunology and Immunotherapy

Computational Methods in the Design of Anticancer Drugs

In Silico Approaches to Deliver Better Antibodies by Design: The Past, the Present and the Future

Augmenting adaptive immunity: progress and challenges in the quantitative engineering and analysis of adaptive immune receptor repertoires

AI driven B-cell Immunotherapy Design

Structure‐based computational design of antibody mimetics: challenges and perspectives

Vaccine design and development: Exploring the interface with computational biology and AI

Computational Vaccinology and the ICoVax 2012 Workshop

Computational immunogenomic approaches to predict response to cancer immunotherapies

Ten challenges and opportunities in computational immuno-oncology

Historical perspective and future directions: computational science in immuno-oncology

Multi-epitope vaccines, from design to expression; an in silico approach

Computational design of developable therapeutic antibodies: efficient traversal of binder landscapes and rescue of escape mutations

Bioinformatics for cancer immunotherapy target discovery

Predicting Immunogenicity Risk in Biopharmaceuticals

Approaches for deciphering the molecular basis of disease and its translational benefits

Application of germline antibody features to vaccine development, antibody discovery, antibody optimization and disease diagnosis

Advances in Antibody-Based Therapeutics: From Design to Clinical Applications

Antibodies: Computer-Aided Prediction of Structure and Design of Function